Literature DB >> 10758006

Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.

M Julien1, P Gros.   

Abstract

Limited trypsin digestion was used to monitor nucleotide-induced conformational changes in wild-type P-glycoprotein (Pgp) as well as in nucleotide binding domain (NBD) Pgp mutants. Purified and reconstituted wild-type or mutant mouse Mdr3 Pgps were preincubated with different hydrolyzable or nonhydrolyzable nucleotides, followed by limited proteolytic cleavage at different trypsin:protein ratios. The Pgp tryptic digestion products were separated by SDS-PAGE followed by immunodetection with the mouse monoclonal anti-Pgp antibody C219, which recognizes a conserved epitope (VVQE/AALD) in each half of the protein. Different trypsin digestion patterns were observed for wild-type Pgp incubated with MgCl(2) alone, MgADP, MgAMP.PNP, MgATP, and MgATP + vanadate. A unique trypsin digestion profile suggestive of enhanced resistance to trypsin was observed under conditions of vanadate-induced trapping of nucleotides (MgATP + vanadate). The trypsin sensitivity profiles of Pgp mutants bearing either single or double mutations in Walker A (K429R, K1072R) and Walker B (D551N, D1196N) sequence signatures of NBD1 and NBD2 were analyzed under conditions of vanadate-induced trapping of nucleotides. The proteolytic cleavage pattern observed for the double mutants K429R/K1072R and D551N/D1196N, and for the single mutants K429R, K1072R, and D1196N were similar and clearly distinct from wild-type Pgp under the same conditions. This is consistent with the absence of ATP hydrolysis and of vanadate-induced trapping of 8-azido-ADP previously reported for these mutants [Urbatsch et al. (1998) Biochemistry 37, 4592-4602]. Interestingly, the trypsin digestion profiles observed under vanadate-induced trapping for the D551N and D1196N mutants were quite different, with the D551N mutant showing a profile resembling that seen for wild-type Pgp. The different sensitivity profiles of Pgp mutants bearing mutations at the homologous residue in NBD1 (D551N) and NBD2 (D1196N) suggest possible structural and functional differences between the two sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758006     DOI: 10.1021/bi992744z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.

Authors:  Paula L Russell; Frances J Sharom
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

2.  Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.

Authors:  M F Rosenberg; G Velarde; R C Ford; C Martin; G Berridge; I D Kerr; R Callaghan; A Schmidlin; C Wooding; K J Linton; C F Higgins
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis.

Authors:  Carla P Guimarães; Clara Sá-Miranda; Jorge E Azevedo
Journal:  J Hum Genet       Date:  2005-01-29       Impact factor: 3.172

4.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

5.  Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.

Authors:  Emily Crowley; Megan L O'Mara; Catherine Reynolds; D Peter Tieleman; Janet Storm; Ian D Kerr; Richard Callaghan
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

6.  Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity.

Authors:  Cátia A Bonito; Ricardo J Ferreira; Maria-José U Ferreira; Jean-Pierre Gillet; M Natália D S Cordeiro; Daniel J V A Dos Santos
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

7.  The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.

Authors:  Jason Goebel; Jean Chmielewski; Christine A Hrycyna
Journal:  Cancer Drug Resist       Date:  2021-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.